Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase i study of the Gynecologic Oncology Group

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 224-228

  Kunos, Charles A ^a   Sill, Michael W ^b   Buekers, Thomas E ^c   Walker, Joan L ^d   Schilder, Jeanne M ^e   Yamada, S Diane ^f   Waggoner, Steven E ^a   Mohiuddin, Mohammed ^g,i   Fracasso, Paula M ^h  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Buffalo Niagara Enterprise   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Abdominal radiation; Chemosensitizer; Docetaxel; Ovarian cancer

Indexed keywords

ANTIEMETIC AGENT; CA 125 ANTIGEN; DEXAMETHASONE; DOCETAXEL; HEMOGLOBIN;

ABDOMINAL RADIOTHERAPY; ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CHEMOSENSITIZATION; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; EPISTAXIS; FATIGUE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INDUCED HYPOTENSION; LOW DRUG DOSE; LOW ENERGY RADIATION; MAXIMUM TOLERATED DOSE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MYALGIA; NEUTROPENIA; NEUTROPHIL COUNT; OVARY CANCER; OVARY CARCINOMA; PERITONEUM CANCER; PHARYNGITIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SENSORY NEUROPATHY; SEPTICEMIA; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; STOMATITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UTERINE TUBE CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; TAXOIDS; TREATMENT OUTCOME;

EID: 79251599499     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.018     Document Type: Article

References (25)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. S.A. Cannistra Cancer of the ovary New Engl J Med 351 2004 2510 2529
3. A. Mauer, G. Masters, and D. Haraf A phase I study of docetaxel with concomitant thoracic radiation therapy J Clin Oncol 16 1998 1
4. J. Hainsworth, H.I. Burris, and F. Greco Weekly administration of docetaxel (Taxotere): summary of clinical data Semin Oncol 26 1999 19 24
5. J. Kavanagh, A. Kudelka, and C. de Leon Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum Clin Cancer Res 2 1996 837 842
6. S. Kaye, M. Piccart, and M. Aapro Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer-an updated overview Eur J Cancer 33 1997 2167 2170
7. C. Verschraegen, T. Sittisomwong, and A. Kudelka Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma J Clin Oncol 18 2000 2733 2739
8. P. Rose, J. Blessing, and H. Ball A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 88 2003 130 135
9. E. Hall, and A. Garcia Clinical response of normal tissues Radiobiology for the Radiologist, Vol Sixth edition 2006 Lippincott Williams & Wilkins Philadelphia 341
10. M. Randall, R. Barrett, and N. Spirtos Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer Int J Radiat Oncol Biol Phys 34 1996 139 147
11. S. Reddy, M. Lee, and E. Yordan Salvage whole abdomen radiation therapy: its role in ovarian cancer Int J Radiat Oncol Biol Phys 1993 27-879-84.
12. P. Eifel, D. Gershenson, and L. Delclos Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma Int J Radiat Oncol Biol Phys 21 1991 1013 1018
13. B. Corn, R. Lanciano, and M. Boente Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure Cancer 74 1994 2979 2983
14. A. Dembo, R. Bush, and F. Beale Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation Am J Obstet Gynecol 134 1979 793 800
15. S. Firat, K. Murray, and B. Erickson High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: Long-term toxicity and outcomes Int J Radiat Oncol Biol Phys 57 2003 201 207
16. D. Chendil, R. Oakes, and R. Alcock Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53 Cancer 2000 891893 891900
17. E. Hall, and A. Garcia Time, dose, and fractionation in radiotherapy Radiobiology for the Radiologist, Vol Sixth edition 2006 Lippincott Williams & Wilkins Philadelphia 378 397
18. E. Briasoulis, V. Karavasillis, and D. Anastasopoloulos Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration Ann Oncol 10 1999 701 706
19. P. Therasse, S. Arbuck, and E. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
20. S. Arnold, W. Regine, and M. Ahmed Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm Int J Radiat Oncol Biol Phys 58 2004 1411 1417
21. W. Wallace, A. Thomson, and T. Kelsey The radiosensitivity of the human oocyte Hum Reprod 18 2003 117 121
22. I. Adriaens, J. Smitz, and P. Jacquet The current knowledge on radiosensitivity of ovarian follicle development stages Hum Reprod Update 15 2009 359 377
23. G. Thomas Radiotherapy in early ovarian cancer Gynecol Oncol 55 1994 S73 S79
24. A. Dembo Epithelial ovarian cancer: the role of radiotherapy Int J Radiat Oncol Biol Phys 22 1992 835 845
25. M. Engelen, B. Snel, M. Schaapveld, E. Pras, E. de Vries, and J. Gietema Long-term morbidity of adjuvant whole-abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer Eur J Cancer 45 2009 1193 1200